Schreiber, Robert D.

Ligand‐induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91).

Greenlund, A. C., Farrar, M. A., Viviano, B. L., & Schreiber, R. D. (1994) · The EMBO Journal

Cytokine Signaling Pathways and Interactionsinterferon and immune responses

Cited by 454

Synergy between Interferon-γ and Tumor Necrosis Factor-α in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κB

Ohmori, Y., Schreiber, R. D., & Hamilton, T. A. (1997) · Journal of Biological Chemistry

Cytokine Signaling Pathways and InteractionsNF-κB Signaling Pathways

Cited by 413

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

Guidotti, L. G., Ando, K., Hobbs, M. V., Ishikawa, T., Runkel, L., Schreiber, R. D., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences

Hepatitis B Virus StudiesHepatitis C virus research

Cited by 412

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

Vesely, M. D., & Schreiber, R. D. (2013) · Annals of the New York Academy of Sciences

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 367

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

O’Sullivan, T., Saddawi-Konefka, R., Vermi, W., Koebel, C. M., Arthur, C., White, J. M., Uppaluri, R., Andrews, D. M., Ngiow, S. F., Teng, M. W. L., et al. (2012) · Journal of Experimental Medicine

Immune cells in cancerImmunotherapy and Immune Responses

Cited by 348

Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling

Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine

T-cell and B-cell ImmunologyRheumatoid Arthritis Research and Therapies

Cited by 287

Stat3 Recruitment by Two Distinct Ligand-induced, Tyrosine-phosphorylated Docking Sites in the Interleukin-10 Receptor Intracellular Domain

Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E., & Schreiber, R. D. (1996) · Journal of Biological Chemistry

Cytokine Signaling Pathways and InteractionsReceptor Mechanisms and Signaling

Cited by 218

Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.

Ando, K., Guidotti, L. G., Wirth, S., Ishikawa, T., Missale, G., Moriyama, T., Schreiber, R. D., Schlicht, H. J., Huang, S. N., & Chisari, F. V. (1994) · The Journal of Immunology

T-cell and B-cell ImmunologyHepatitis B Virus Studies

Cited by 201

Ligand-Induced Assembly and Activation of the Gamma Interferon Receptor in Intact Cells

Bach, E. A., Tanner, J. W., Marsters, S., Ashkenazi, A., Aguet, M., Shaw, A. S., & Schreiber, R. D. (1996) · Molecular and Cellular Biology

Cytokine Signaling Pathways and Interactionsinterferon and immune responses

Cited by 145

Identification of an Interferon-γ Receptor α Chain Sequence Required for JAK-1 Binding

Kaplan, D. H., Greenlund, A. C., Tanner, J. W., Shaw, A. S., & Schreiber, R. D. (1996) · Journal of Biological Chemistry

Cytokine Signaling Pathways and Interactionsinterferon and immune responses

Cited by 105

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Gubin, M. M., Esaulova, E., Ward, J. P., Malkova, O. N., Runci, D., Wong, P., Noguchi, T., Arthur, C. D., Meng, W., Alspach, E., et al. (2018) · Cell

Cancer Immunotherapy and BiomarkersImmune cells in cancer

Cited by 98

TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy

Di Luccia, B., Molgora, M., Khantakova, D., Jaeger, N., Chang, H.-W., Czepielewski, R. S., Helmink, B. A., Onufer, E. J., Fachi, J. L., Bhattarai, B., et al. (2024) · Science Immunology

Cancer Immunotherapy and BiomarkersImmune cells in cancer

Cited by 59

TAK1 targeting by glucocorticoids determines JNK and IκB regulation in Toll-like receptor–stimulated macrophages

Bhattacharyya, S., Ratajczak, C. K., Vogt, S. K., Kelley, C., Colonna, M., Schreiber, R. D., & Muglia, L. J. (2010) · Blood

Immune Response and InflammationNF-κB Signaling Pathways

Cited by 53